Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04927897 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

DETECT: Target Volume for Rectal Endoluminal Radiation Boosting

Study acronym: DETECT
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Eligibility criteria expanded, about 8 words Secondary endpoints: details revised at 8 of 8 entries · Publications: details revised at 23 of 23 entries Show 2 more changesShow less
    • Secondary endpoints: details revised at 8 of 8 entries
    • Publications: details revised at 23 of 23 entries
  2. Primary completion date: Dec 2024 to May 2027 Completion date: Dec 2024 to Dec 2027v5 Show 1 more changeShow less
    • Completion date: Dec 2024 to Dec 2027
  3. Re-verified, no change to tracked fieldsv4
  4. Trial status: Not Yet Recruiting to Recruiting Primary and study completion dates: Apr 2023 to Dec 2024 · Start date changed from estimate of Oct 2021 to Aug 16, 2022 · Interventions: MRI (resection specimen) (Other), Rectoscopy (Diagnostic Test), Ultrasound (Diagnostic Test) to Rectoscopy (Diagnostic Test), Scan, e.g. CT (resection specimen) (Other), Ultrasound (Diagnostic Test) · 2 morev3 Show 5 more changesShow less
    • Primary and study completion dates: Apr 2023 to Dec 2024
    • Start date changed from estimate of Oct 2021 to Aug 16, 2022
    • Interventions: MRI (resection specimen) (Other), Rectoscopy (Diagnostic Test), Ultrasound (Diagnostic Test) to Rectoscopy (Diagnostic Test), Scan, e.g. CT (resection specimen) (Other), Ultrasound (Diagnostic Test)
    • Study description expanded, about 10 words
    • Site details revised at 3 of 3 sites

    See this version in full on ClinicalTrials.gov ↗

  5. Start date: Jul 2021 to Oct 2021 Primary and study completion dates: Dec 2022 to Apr 2023 · Eligibility criteria expanded, about 48 words · Secondary endpoints: details revised at 4 of 8 entries · 1 morev2 Show 4 more changesShow less
    • Primary and study completion dates: Dec 2022 to Apr 2023
    • Eligibility criteria expanded, about 48 words
    • Secondary endpoints: details revised at 4 of 8 entries
    • Site contacts updated at 3 of 3 sites

    See this version in full on ClinicalTrials.gov ↗

  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to provide prospective data regarding microscopic tumor spread in all directions from the macroscopic tumor in pathology specimens, as seen by eye, and on imaging to define the target volume for endoluminal radiation boosting in rectal cancer patients.
Trial Details
NCT Number NCT04927897
Lead Sponsor Maastricht Radiation Oncology
Collaborators: Maastricht University Medical Center, Catharina Ziekenhuis Eindhoven
Conditions Rectal Cancer
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov